The One Area Where Democrats Should Follow Trump’s Lead
Nowhere is the case for public ownership than in the defense sector. LUTNICK – Like Trump, a broken clock – was just when he said that companies like Lockheed Martin were already working like almost public entities, drawing almost all their income from government contracts. They are indeed state companies present themselves to private profits.
The same logic applies, even more urgent, to fossil fuels. The oil and gas companies are enormous beneficiaries of public support in the form of subsidies, tax alternatives and infrastructure guarantees. Their basic incentive is to extract and burn as much carbon as possible humanly. No serious observer always thinks that the free market can manage the climate crisis. The nationalization would not only guarantee that large sums of public money already flowing in fossil fuels gives a return for taxpayers. This would also make a transition managed and just far from carbon possible. Norway state belonging Oil Company has shown that public property is not only Feasable but profitable.
Pharmaceutical products form the third pillar of this argument. All three are areas of life or death where markets regularly fail people with deadly consequences. The most profitable products in the industry are massively built on the back of the research funded by the public, a large part funded by the National Institutes of Health. Between 2010 and 2019, each of the 356 new drugs approved by the FDA has drawn its origins in science funded by NIH, according to a Paper 2020 by the Institute of New Economic Thought. However, the profits accumulate almost entirely to private companies, which charge at the prices of exorbitant public drugs which he has actually paid to invent. (Trump, meanwhile, has reduced nearly $ 2 billion in research grants to NIH, eliminating the research pipeline, which makes these breakthroughs possible.) Taxpayers finance the breakthroughs, but are then forced to buy them at swollen prices, often at the cost of debt or refused care.
